Walgreens shuts 40 Theranos outlets after ending partnership

Theranos’ reputation has already been damaged after it issued tens of thousands of corrected or voided results to former patients, and has been subject to investigations by the U.S. Securities and Exchange Commission, the U.S. attorney’s office in San Francisco, and federal and state health regulators.

“In light of the voiding of a number of test results, and as the Centers for Medicare and Medicaid Services has rejected Theranos’ plan of correction and considers sanctions, we have carefully considered our relationship with Theranos and believe it is in our customers’ best interests to terminate our partnership,” Brad Fluegel, Walgreens’ chief health care commercial market development officer, said in the statement.

“We are disappointed that Walgreens has chosen to terminate our relationship and remain fully committed to our mission to provide patients access to affordable health information and look forward to continuing to serve customers in Arizona and California through our retail locations,” Brooke Buchanan, a spokeswoman for Theranos, said in an email.